Close

Rating History for Transcept Pharmaceuticals (TSPT) by Lazard Capital

More Stocks Rated by Lazard Capital | Latest Ratings for TSPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/5/2011 N/A Upgrade Buy
(N/A)		 22.00
(N/A)		 8.08
(7.20)		 -10.89% Details